750 related articles for article (PubMed ID: 26873707)
1. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.
Kajdácsi E; Jani PK; Csuka D; Varga LÁ; Prohászka Z; Farkas H; Cervenak L
J Allergy Clin Immunol; 2014 Jun; 133(6):1686-91. PubMed ID: 24522092
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
5. Hereditary angioedema attack: what happens to vasoactive mediators?
Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S
Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756
[TBL] [Abstract][Full Text] [Related]
6. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
8. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
9. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L
Front Immunol; 2020; 11():794. PubMed ID: 32431708
[TBL] [Abstract][Full Text] [Related]
10. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
[TBL] [Abstract][Full Text] [Related]
12. Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.
Csuka D; Munthe-Fog L; Hein E; Zotter Z; Prohászka Z; Farkas H; Varga L; Garred P
J Allergy Clin Immunol; 2014 Dec; 134(6):1388-1393.e1. PubMed ID: 25042985
[TBL] [Abstract][Full Text] [Related]
13. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF
Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674
[TBL] [Abstract][Full Text] [Related]
14. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
16. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
17. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
18. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
[TBL] [Abstract][Full Text] [Related]
19. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]